Neonatal Genetic Delivery of Anti-Respiratory Syncytial Virus (RSV) Antibody by Non-Human Primate-Based Adenoviral Vector to Provide Protection against RSV

Respiratory syncytial virus (RSV) is one of the leading causes of lower respiratory tract infection in infants. Immunoprophylaxis with the anti-RSV monoclonal antibody, palivizumab, reduces the risk for RSV-related hospitalizations, but its use is restricted to high-risk infants due to the high cost...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Rika Gomi, Anurag Sharma, Wenzhu Wu, Stefan Worgall
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2018-12-01
coleção:	Vaccines
Assuntos:	respiratory syncytial virus (RSV) immunoprophylaxis palivizumab chimpanzee adenovirus type 7 (AdC7) neonate passive immunization genetic gene delivery
Acesso em linha:	http://www.mdpi.com/2076-393X/7/1/3
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!